Literature DB >> 11342419

Highly heterogeneous nature of delta-aminolevulinate dehydratase (ALAD) deficiencies in ALAD porphyria.

M Maruno1, K Furuyama, R Akagi, Y Horie, K Meguro, L Garbaczewski, N Chiorazzi, M O Doss, A Hassoun, R Mercelis, L Verstraeten, P Harper, Y Floderus, S Thunell, S Sassa.   

Abstract

The properties of 9 delta-aminolevulinate dehydratase (ALAD) mutants from patients with ALAD porphyria (ADP) were examined by bacterial expression of their complementary DNAs and by enzymologic and immunologic assays. ALADs were expressed as glutathione-S-transferase (GST) fusion proteins in Escherichia coli and purified by glutathione-affinity column chromatography. The GST-ALAD fusion proteins were recognized by anti-ALAD antibodies and were enzymatically active as ALAD. The enzymatic activities of 3 ALAD mutants, K59N, A274T, and V153M, were 69.9%, 19.3%, and 41.0% of that of the wild-type ALAD, respectively, whereas 6 mutants, G133R, K59N/G133R, F12L, R240W, V275M, and delTC, showed little activity (< 8%). These variations generally reflect the phenotype of ALAD in vivo in patients with ADP and indicate that GST-ALAD fusion protein is indeed useful for predicting of the phenotype of ALAD mutants. The location of F12L mutation in the enzyme's molecular structure indicates that its disturbance of the quaternary contact of the ALAD dimer appears to have a significant influence on the enzymatic activity. Mouse monoclonal antibodies to human ALAD were developed that specifically recognized a carboxy terminal portion of ALAD, or other regions in the enzyme. This study represents the first complete analysis of 9 mutants of ALAD identified in ADP and indicates the highly heterogeneous nature of mutations in this disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342419     DOI: 10.1182/blood.v97.10.2972

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  ALAD porphyria is a conformational disease.

Authors:  Eileen K Jaffe; Linda Stith
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

Review 2.  Allostery and the dynamic oligomerization of porphobilinogen synthase.

Authors:  Eileen K Jaffe; Sarah H Lawrence
Journal:  Arch Biochem Biophys       Date:  2011-10-19       Impact factor: 4.013

3.  MORPHEEINS - A NEW PATHWAY FOR ALLOSTERIC DRUG DISCOVERY.

Authors:  Eileen K Jaffe
Journal:  Open Conf Proc J       Date:  2010

4.  Environmental contaminants perturb fragile protein assemblies and inhibit normal protein function.

Authors:  Sarah H Lawrence; Trevor Selwood; Eileen K Jaffe
Journal:  Curr Chem Biol       Date:  2013

Review 5.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

6.  Transposase-derived proteins FHY3/FAR1 interact with PHYTOCHROME-INTERACTING FACTOR1 to regulate chlorophyll biosynthesis by modulating HEMB1 during deetiolation in Arabidopsis.

Authors:  Weijiang Tang; Wanqing Wang; Dongqin Chen; Qiang Ji; Yanjun Jing; Haiyang Wang; Rongcheng Lin
Journal:  Plant Cell       Date:  2012-05-25       Impact factor: 11.277

7.  Diverse clinical compounds alter the quaternary structure and inhibit the activity of an essential enzyme.

Authors:  Sarah H Lawrence; Trevor Selwood; Eileen K Jaffe
Journal:  ChemMedChem       Date:  2011-04-19       Impact factor: 3.466

Review 8.  Porphyrias in Japan: compilation of all cases reported through 2002.

Authors:  Masao Kondo; Yuzo Yano; Masuo Shirataka; Gumpei Urata; Shigeru Sassa
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

9.  Allosteric inhibition of human porphobilinogen synthase.

Authors:  Sarah H Lawrence; Ursula D Ramirez; Trevor Selwood; Linda Stith; Eileen K Jaffe
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

10.  The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany.

Authors:  M O Doss; T Stauch; U Gross; M Renz; R Akagi; M Doss-Frank; H P Seelig; S Sassa
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.